ArticleFrontiers in immunology2025

Dissecting the immune evasion and therapeutic resistance mechanisms in EGFR/TP53 co-mutated non-small cell lung cancer: implications for targeted and immunotherapy strategies.

Haiyan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.